Skip to search formSkip to main contentSkip to account menu

recurrent osteosarcoma

Known as: Relapsed Osteosarcoma, Relapsed Osteogenic Sarcoma, Osteosarcoma, Recurrent 
The reemergence of osteosarcoma after a period of remission.
National Institutes of Health

Related topics

Related topics

9 relations
Connective Tissue CellsConnective and Soft TissueEpithelial CellsEpithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
ABSTRACT Previously, a patient-derived orthotopic xenograft (PDOX) model was established with a lung metastasis from an… 
Highly Cited
2016
Highly Cited
2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Robatumumab (19D12; MK‐7454 otherwise known as SCH717454) is a fully human antibody that binds to and inhibits insulin‐like… 
Highly Cited
2016
Highly Cited
2016
Comparison of 18F‐FDG‐PET‐CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma
Bone scintigraphy (BS) is used to detect osseous metastases in osteosarcoma. 18F‐fluorodeoxyglucose‐positron emission tomography… 
Highly Cited
2012
Highly Cited
2012
Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
BackgroundImmunotherapy using autologous dendritic cell (DC) vaccination has not been systematically evaluated in osteosarcoma… 
2006
2006
Survival after recurrence of osteosarcoma: A 20‐year experience at a single institution
Approximately one‐third of patients with osteosarcoma who have a complete response to their initial treatment can be expected to… 
Highly Cited
2004
Highly Cited
2004
Evaluation of P‐glycoprotein, HER‐2/ErbB‐2, p53, and Bcl‐2 in primary tumor and metachronous lung metastases in patients with high‐grade osteosarcoma
Investigation of the relation between primary tumor and metastatic disease is necessary for the identification of predictive… 
2002
2002
Treatment of Refractory Osteosarcoma With Fractionated Cyclophosphamide and Etoposide
Purpose Standard multiagent chemotherapy for osteosarcoma may include platinum compounds, doxorubicin, and high-dose methotrexate… 
Highly Cited
1995
Highly Cited
1995
Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma
Muramyl tripeptide phosphatidylethanolamine (MTP-PE) is a synthesized lipophilic analogue of muramyl dipeptide. MTP-PE… 
Review
1995
Review
1995
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
Highly Cited
1993
Highly Cited
1993
Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE), a new biologic response modifier, was designed to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)